Acute chest syndrome and COVID‐19 in hydroxyurea naïve sickle cell disease patient in a low resource setting

Acute chest syndrome (ACS) is a severe complication of sickle cell disease (SCD) and one of the leading causes of mortality in SCD patients. The management of ACS is challenging and requires prompt intervention to halt clinical deterioration. With the outbreak of the Coronavirus Disease 2019 (COVID‐...

Descripción completa

Detalles Bibliográficos
Autores principales: Mawalla, William Frank, Nasser, Ahlam, Jingu, James Salumu, Joseph, Happiness, Mmbaga, Lilian Gasper, Shija, Eunice, Kakumbula, Helena, Lubuva, Neema Budodi, Meda, Collins, Chamba, Clara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110990/
https://www.ncbi.nlm.nih.gov/pubmed/35602245
http://dx.doi.org/10.1002/jha2.397

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110990/
https://www.ncbi.nlm.nih.gov/pubmed/35602245
http://dx.doi.org/10.1002/jha2.397

Ejemplares similares